Business journalist Gary Weiss, writing for Portfolio.com, notes that the litigation by a small biotech company against a hedge fund and a research firm has ended with an apology from the company and money being paid, but the media that ran stories sympathetic to the cause of small companies being shorted by investors have yet to apologize or update their viewers.
“NBC has never revisited its Eagletech story, and neither has CBS clued in its viewers on the denouement of its Biovail story, either on the air or in the long article that CBS published on its website at the time of the broadcast. Not one word about the guilty plea, the SEC woes, or last week’s apologies.
“It seems to me that another apology is needed: an apology from CBS, not to Gradient or SAC, but to its viewers.”
Read more here.
Wall Street Journal editor in chief Emma Tucker sent out the following on Friday: Dear…
New York Times metro editor Nestor Ramos sent out the following on Friday: We are delighted to…
Rahat Kapur of Campaign looks at the evolution The Wall Street Journal. Kapur writes, "The transformation…
This position will be Hybrid in the office/market 3 days per week, and those days…
The Fund for American Studies presented James Bennet of The Economist with the Kenneth Y. Tomlinson Award…
The Wall Street Journal is experimenting with AI-generated article summaries that appear at the top…